ÃâÒßѧÊÔÌâ
9Uk9TG 5 Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
sb8SG_ c. 1. Fas(CD95)/FasL
r5F#q 2. common chain of cytokine receptor
cvc.-7IO 3 . TCR/CD3 complex
[c3hwogf: 4. negaive selection of thymocytes
r2H]n.MT 5. artificial active immune
tb_}w@:kU 6. anti-idiotypic
%=NqxF>> 7. IgSF
]bX.w/= 8. Integrin
f)gA.Rz 9. chemokine
hS<x+|'l 10. B7/CD28
`cVG_=2 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
\7Zk[)!FL 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
jIuE1ve 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
?2.<y_1 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
"esV#%:#J 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
hX[hR
|ss_< 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
~9x$tb x- µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
u*PN1E Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
-LQ%)'J ZN 1. B7/CD28
N)&3(A@ 2. Th1 subset
Q2iu}~ 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
x+^iEj`gk 4. antibody affinity maturation
"z7.i{
5. AP-1
T;.#=h 6. single chain variable fragment£¨ScFv£©
T4w`I;&v 7. NK cell receptor
wYNh0QlBH 8. Zinkernagel-Doherty phenomenon
&K|CH?
D 9. Ig fold
lwjg57 10. CD40/CD40L
+FyG{1?< ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
8'/vW ~f 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
iQs(Dh=* 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
)I`B+c: 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
<C]s\"o-` Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
Y+j|T`d 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
\%rX~UhZ= 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
*7DQ#bD 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
ob-z-iDz Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
&P,8)YA £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
M0 =K#/ Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
l}K{=%U>7 1.Co-stimulators (or co-stimulating molecules)
beN0?G 2.NK-kB
.k Gg} 3.Immunoglobulin superfamily
#k5Nnv#(J 4.antigen-presenting cell (APC)
)0~zL} )? 5.death domain
,7z.%g3+z 6.CCR and CXCR
*)H?d 7.Lectin (or mitogen)
c$bb0J% 8.Clusters of differentiation, CD)
`a98+x?JF 9.B7 family
{!Jw+LPv$$ 10.Cytotoxic T lymphocyte, CTL)
|^8l8u 11.IL-15 and IL-15 receptor (IL-15R)
b~WiE? 12.MHC restriction
MG<F.u 13.Affinity-chromatography
$wub)^ 14.Cyctosprin A, CsA
C`%
cPl 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
4&&((H
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
w0q.cj@nd 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
Xg_M{t 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
iYEhrb 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
u|BD=4* Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
T/X[q7O~~4 ÃâÒßѧרҵ£º
DW\';" 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
jhr:QS/9 Ïû»¯ÄÚ¿Æ£º
&O/;YGEAB 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
2g$PEwXe ѪҺ²¡Ñ§×¨Òµ£º
7y""#-}V[r 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
f!|7j}3 Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
\7n ;c (רҵ»ù´¡: ÃâÒßѧ)
k?zw4S Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
k)U9%Pr
1. ADCC(antibody dependent cell-mediated cytotoxicity)
qb'4x){ 2. »·æß¾úËØ(cyclosporin)
OuWG.Za 3. KIR(killer cell inhibitory receptor)
!VBl/ aU@ 4. HLDA(human leucocyte differentiation antigen)
`!V=~"ve 5. Interleukin 18(IL-18)
1U[Q)(P 6. ÕûºÏËØ(integrin)
(1Q G]1q 7. Fas/FasL
-9W)|toWb" 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
fhp\of/@
R 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
qtlXDgppO 10. Th1/Th2
4}-{sS}MP 11. »ùÒòÒßÃç(DNAÒßÃç)
*f<+yF{=A 12. chemokines and chemokine receptor
E "9` 13. ÃâÒßÄÍÊÜ
%QY
W0lE 14. ¹²´Ì¼¤·Ö×Ó
.Y`;{) 15. ËÀÍö½á¹¹Óò(death domain)
5AFy6Ab ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
SlK6KnX 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
at<N?r 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
B L^?1x £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
vT1StOx<V £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
Y8l
8B> £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
dbVMG-z8 £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
OQ*BPmS-
3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
76 ]X Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
"|k 4<"] ÎÊ´ðÌâ(ÿÌâ25·Ö)
OS-
Xh-:z 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
E!Ljq 3iT` 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
fGtYvl O-5 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
M_BG:P5 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£